Leaflet SILGARD suspension for injection in pre-filled syringe
Indicated for: prevention of human papillomavirus infection
Route of administration: injectable
Substance: papillomavirus vaccine (type 6, 11, 16 and 18) (vaccine)
ATC: J07BM01 (Antiinfectives for systemic use | Viral vaccines | Papillomavirus vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The human papillomavirus (HPV) vaccine, which protects against types 6, 11, 16, and 18, is used to prevent HPV infections and associated conditions such as genital warts and cancers of the cervix, vulva, vagina, and anus. Types 16 and 18 are responsible for the majority of cervical cancer cases, while types 6 and 11 cause most genital warts.
The vaccine is administered intramuscularly, usually in three doses over a six-month period, and is recommended for both girls and boys starting at ages 9-12, before exposure to the virus.
Common side effects include pain at the injection site, mild fever, headache, and fatigue. In rare cases, severe allergic reactions may occur.
The HPV vaccine (types 6, 11, 16, and 18) is an essential measure for preventing HPV-associated cancers and other conditions, helping to reduce the burden of diseases caused by this virus.
General data about SILGARD
- Substance: papillomavirus vaccine (type 6, 11, 16 and 18)
- Date of last drug list: 01-07-2020
- Commercial code: W51742005
- Pharmaceutical form: suspension for injection in pre-filled syringe
- Quantity: 1
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).